Dr. Fabian Peissker is a seasoned Global Medical Affairs specialist with extensive experience across diverse fields of medicine. Since 2014, his work has been centered on the development and application of plasma-derived immunoglobulins for their multifaceted indications. Dr. Peissker's academic journey began with his high school graduation in Wolfenbüttel, Germany, in 1987, followed by compulsory military service. He pursued studies in Chemistry and Biochemistry at TU Braunschweig, completing his education in 1994 and earning a PhD in Protein Biochemistry in 1998.

Dr. Peissker's professional career began in protein downstream process development at a biotech start-up. Since 2000, he has held various leadership roles in National and Global Medical Affairs Management, Medical Education, Clinical Research Management, and as a Corporate Medical Science Liaison. His experience spans globally recognized organizations, including Merck, Serono, Mundipharma, Biotest, Ferrer, and Kedrion Biopharma. Currently, he focuses on Medical Affairs Management in Western Europe, particularly in the UK, Germany, and Austria, where he supports the use of plasma-derived immunoglobulins in treating rare and ultra-rare diseases.